ESTRELLA IMMUNOPHARMA, INC. (ESLAW) Return on equity
ESTRELLA IMMUNOPHARMA, INC. (ESLAW) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to ESLAWSource: SEC XBRL filings · For reference only · Not investment advice
More ESLAW financial trends
ESLAW RevenueESLAW Net incomeESLAW Net marginESLAW Gross profitESLAW Gross marginESLAW Operating incomeESLAW Operating marginESLAW Operating cash flowESLAW Free cash flowESLAW Capital expendituresESLAW Stock buybacksESLAW Dividends paidESLAW Total assetsESLAW Total liabilitiesESLAW Shareholders’ equityESLAW overview →